The Clinical Evidence-Based Paradigm of Topical Anti-Aging Skincare Formulations Enriched with Bio-Active Peptide SA1-III (KP1) as Collagen Modulator: From Bench to Bedside [Corrigendum]

Rovero P, Malgapo DMH, Sparavigna A, Beilin G, Wong V, Lao MP. Clin Cosmet Investig Dermatol. 2022;15:2693–2703.

The authors have advised that there is an error in the Study characteristics for Face serum (ISPE, 2022) in Table 2 on page 2698. The correct Table 2 is as follows.

Table 2 Results of Instrumental and Subjective Evaluations of SA1-III Face Cream and Face Serum

The authors apologise for this error.

Read the original article

© 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.